Amgen is cutting the price of its costly cholesterol drug from $14k/year to $5,850, bowing to political and business realities. Read more from @kristenvbrownhttps://www.bloomberg.com/news/articles/2018-10-24/amgen-cuts-cholesterol-drug-s-price-60-after-lackluster-sales …
0 replies
4 retweets
5 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.